Sarepta Therapeutics To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday

sarepta therapeutics會上漲約30%？這裏是週四的十大分析師預測

Benzinga · 11/07 21:34

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Piper Sandler boosted Duolingo, Inc. (NASDAQ:DUOL) price target from $271 to $351. Piper Sandler analyst Arvind Ramnani maintained an Overweight rating. Duolingo shares closed at $318.85 on Wednesday. See how other analysts view this stock.
B of A Securities cut the price target for Bloom Energy Corporation (NYSE:BE) from $8 to $7. B of A Securities analyst Julien Dumoulin-Smith maintained an Underperform rating. Bloom Energy shares closed at $10.97 on Wednesday. See how other analysts view this stock.
Needham raised the price target for Vertex, Inc. (NASDAQ:VERX) from $45 to $60. Needham analyst Joshua Reilly maintained a Buy rating. Vertex shares closed at $49.76 on Wednesday. See how other analysts view this stock.
Baird increased McKesson Corporation (NYSE:MCK) price target from $531 to $688. Baird analyst Eric Coldwell upgraded the stock from Neutral to Outperform. McKesson shares settled at $549.31 on Wednesday. See how other analysts view this stock.
TD Cowen raised Dutch Bros Inc. (NYSE:BROS) price target from $47 to $53. TD Cowen analyst Andrew Charles maintained a Buy rating. Dutch Bros shares closed at $34.94 on Wednesday. See how other analysts view this stock.
Truist Securities cut Devon Energy Corporation (NYSE:DVN) price target from $49 to $43. Truist Securities analyst Neal Dingmann downgraded the stock from Buy to Hold. Devon Energy shares closed at $40.02 on Wednesday. See how other analysts view this stock.
Cantor Fitzgerald raised the price target for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) from $152 to $167. Cantor Fitzgerald analyst Kristen Kluska upgradd the stock from Neutral to Overweight. Sarepta shares settled at $127.97 on Wednesday. See how other analysts view this stock.
Leerink Partners raised Zymeworks Inc. (NASDAQ:ZYME) price target from $10 to $25. Leerink Partners analyst Andrew Berens upgraded the stock from Market Perform to Outperform. Zymeworks shares closed at $15.61 on Wednesday. See how other analysts view this stock.
Loop Capital slashed the price target for Crocs, Inc. (NYSE:CROX) from $150 to $110. Loop Capital analyst Laura Champine downgraded the stock from Buy to Hold. Crocs shares closed at $102.74 on Wednesday. See how other analysts view this stock.
Keefe, Bruyette & Woods increased Lemonade, Inc. (NYSE:LMND) price target from $18 to $21. Keefe, Bruyette & Woods analyst Thomas McJoynt-Griffith downgraded the stock from Market Perform to Underperform. Lemonade shares closed at $29.29 on Wednesday. See how other analysts view this stock.

Jim Cramer: This Financial Stock Is A Buy, Likes Broadcom

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

華爾街頂級分析師改變了對這些頂級公司的展望。如需查看包括升級和降級在內的所有分析師評級變化的完整視圖，請參閱我們的分析師評級頁面。

Piper Sandler boosted Duolingo, Inc. (NASDAQ:DUOL) price target from $271 to $351. Piper Sandler analyst Arvind Ramnani maintained an Overweight rating. Duolingo shares closed at $318.85 on Wednesday. See how other analysts view this stock.
B of A Securities cut the price target for Bloom Energy Corporation (NYSE:BE) from $8 to $7. B of A Securities analyst Julien Dumoulin-Smith maintained an Underperform rating. Bloom Energy shares closed at $10.97 on Wednesday. See how other analysts view this stock.
Needham raised the price target for Vertex, Inc. (NASDAQ:VERX) from $45 to $60. Needham analyst Joshua Reilly maintained a Buy rating. Vertex shares closed at $49.76 on Wednesday. See how other analysts view this stock.
Baird increased McKesson Corporation (NYSE:MCK) price target from $531 to $688. Baird analyst Eric Coldwell upgraded the stock from Neutral to Outperform. McKesson shares settled at $549.31 on Wednesday. See how other analysts view this stock.
TD Cowen raised Dutch Bros Inc. (NYSE:BROS) price target from $47 to $53. TD Cowen analyst Andrew Charles maintained a Buy rating. Dutch Bros shares closed at $34.94 on Wednesday. See how other analysts view this stock.
Truist Securities cut Devon Energy Corporation (NYSE:DVN) price target from $49 to $43. Truist Securities analyst Neal Dingmann downgraded the stock from Buy to Hold. Devon Energy shares closed at $40.02 on Wednesday. See how other analysts view this stock.
Cantor Fitzgerald raised the price target for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) from $152 to $167. Cantor Fitzgerald analyst Kristen Kluska upgradd the stock from Neutral to Overweight. Sarepta shares settled at $127.97 on Wednesday. See how other analysts view this stock.
Leerink Partners raised Zymeworks Inc. (NASDAQ:ZYME) price target from $10 to $25. Leerink Partners analyst Andrew Berens upgraded the stock from Market Perform to Outperform. Zymeworks shares closed at $15.61 on Wednesday. See how other analysts view this stock.
Loop Capital slashed the price target for Crocs, Inc. (NYSE:CROX) from $150 to $110. Loop Capital analyst Laura Champine downgraded the stock from Buy to Hold. Crocs shares closed at $102.74 on Wednesday. See how other analysts view this stock.
Keefe, Bruyette & Woods increased Lemonade, Inc. (NYSE:LMND) price target from $18 to $21. Keefe, Bruyette & Woods analyst Thomas McJoynt-Griffith downgraded the stock from Market Perform to Underperform. Lemonade shares closed at $29.29 on Wednesday. See how other analysts view this stock.

派傑投資將Duolingo, Inc. (納斯達克:DUOL)的目標股價從$271提高到$351。派傑投資的分析師Arvind Ramnani維持增持評級。Duolingo股票週三收盤價爲$318.85。看看其他分析師如何看待這隻股票。
美國B證券將Bloom Energy Corporation (紐交所:BE)的目標股價從$8下調至$7。美國B證券的分析師Julien Dumoulin-Smith維持表現不佳評級。Bloom Energy股票週三收盤價爲$10.97。看看其他分析師如何看待這隻股票。
Needham將Vertex, Inc. (納斯達克:VERX)的目標股價從$45上調至$60。Needham的分析師Joshua Reilly維持買入評級。Vertex股票週三收盤價爲$49.76。看看其他分析師如何看待這隻股票。
貝爾德將McKesson Corporation (紐交所:MCK)的目標股價從$531提高至$688。貝爾德的分析師Eric Coldwell將股票評級從中立升級至跑贏大盤。McKesson股票週三收盤價爲$549.31。看看其他分析師如何看待這隻股票。
TD Cowen將Dutch Bros Inc. (紐交所:BROS)的目標股價從$47提高至$53。TD Cowen的分析師Andrew Charles維持買入評級。Dutch Bros股票週三收盤價爲$34.94。看看其他分析師如何看待這隻股票。
Truist Securities將戴文能源公司 (紐交所:DVN)的目標股價從$49下調至$43。Truist Securities的分析師Neal Dingmann將股票評級從買入下調至持有。戴文能源股票週三收盤價爲$40.02。看看其他分析師如何看待這隻股票。
坎特菲茨傑將Sarepta Therapeutics, Inc. (納斯達克:SRPT)的目標股價從$152提高至$167。坎特菲茨傑的分析師Kristen Kluska將股票評級從中立升級至增持。Sarepta股票週三收盤價爲$127.97。看看其他分析師如何看待這隻股票。
Leerink Partners將Zymeworks Inc.（NASDAQ:ZYME）的目標股價從$10上調至$25。Leerink Partners分析師Andrew Berens將該股票的評級從市場執行提升至跑贏市場。週三，Zymeworks股價收盤爲$15.61。看看其他分析師如何看待這支股票。
Loop Capital將Crocs, Inc.（紐交所:CROX）的目標股價從$150下調至$110。Loop Capital分析師Laura Champine將該股票的評級從買入降至持有。週三，Crocs股價收盤於$102.74。查看其他分析師對這支股票的觀點。
Keefe, Bruyette & Woods將Lemonade, Inc.（紐交所:LMND）的目標股價從$18上調至$21。Keefe, Bruyette & Woods分析師Thomas McJoynt-Griffith將該股票的評級從市場執行下調至弱勢。週三，Lemonade股價收盤爲$29.29。查看其他分析師對這支股票的觀點。

閱讀更多：

Jim Cramer: This Financial Stock Is A Buy, Likes Broadcom

吉姆·克萊默：這家金融股值得買入，喜歡博通

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。

Sarepta Therapeutics To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday

Sarepta Therapeutics To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday

風險及免責聲明

聲明